XML 28 R21.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Commitments and Contingencies | 12 Months Ended
--- | ---
Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract] |
Commitments and Contingencies | 14. Commitments and Contingencies Leases The Company’s primary lease represents the lease for its corporate headquarters in Boston, Massachusetts. The Company modified the corporate headquarter lease during the third quarter of 2021. Rent expense for the year ended December 31, 2023 was $4,292. The carrying value of the Company’s right-of-use assets are substantially concentrated in real estate as the Company primarily leases office space. The Company’s policy is not to record leases with an original lease term of one year or less on the consolidated balance sheets. The Company recognizes lease expense for these short-term leases on a straight-line basis over the lease term. The Company does not have any lease contracts with the option to purchase as of December 31, 2023.
|  | Years Ended December 31, |
|  | 2023 |  |  | 2022 |  |  | 2021 |
The components of lease cost under ASC 842 were as follows: |  |  |  |  |  |  |  |  |
Operating lease cost |  | $ | 3,495 |  |  | $ | 3,694 |  |  | $ | 5,617 |
Short-term lease cost |  |  | — |  |  |  | — |  |  |  | — |
Variable lease cost |  |  | — |  |  |  | — |  |  |  | — |
Total lease cost |  | $ | 3,495 |  |  | $ | 3,694 |  |  | $ | 5,617 |
|  | Years Ended December 31, |
|  | 2023 |  |  | 2022 |  |  | 2021 |
Supplemental cash flow information: |  |  |  |  |  |  |  |  |
Cash paid for amounts included in measurement of lease liabilities: |  |  |  |  |  |  |  |  |
Operating cash flows from operating leases |  | $ | 3,527 |  |  | $ | 2,672 |  |  | $ | 6,352 |
Non-cash lease activity: |  |  |  |  |  |  |  |  |
Right-of-use lease assets obtained in exchange for new operating lease liability: |  |  |  |  |  |  |  |  |
Operating leases |  | $ | 0 |  |  | $ | 851 |  |  | $ | 15,506 |
|  | As of December 31, |
|  | 2023 |  |  | 2022 |
Supplemental balance sheet information related to leases is as follows: |  |  |  |  |  |
Operating leases |  |  |  |  |  |
Operating lease right-of-use assets |  | $ | 10,453 |  |  | $ | 13,509 |
Total operating right-of-use lease assets |  | $ | 10,453 |  |  | $ | 13,509 |
Operating lease liabilities, current |  |  | 3,580 |  |  |  | 3,057 |
Operating lease liabilities, net of current portion |  |  | 8,206 |  |  |  | 11,787 |
Total operating lease liabilities |  | $ | 11,786 |  |  | $ | 14,844 |
Weighted-average remaining lease term (in years) |  | 3.2 years |  |  | 4.1 years |
Weighted-average discount rate |  |  | 1.2 | % |  |  | 1.3 | %
As of December 31, 2023, minimum future lease payments for these operating leases were as follows:
Years ending December 31, |  |  |
2024 |  | $ | 3,698 |
2025 |  |  | 3,766 |
2026 |  |  | 3,649 |
2027 |  |  | 893 |
2028 |  |  | — |
Thereafter |  |  | — |
Total lease payments |  | $ | 12,006 |
Less imputed interest |  |  | (220 | )
Total present value of lease liabilities |  | $ | 11,786 |
Indemnification The Company’s arrangements generally include certain provisions for indemnifying clients against third-party claims asserting infringement of certain intellectual property rights in the ordinary course of business. The Company also regularly indemnifies clients against third-party claims that the company’s products or services breach applicable law or regulation or from claims resulting from a breach of the business associate agreement in place with the client. In addition, the Company indemnifies its officers, directors and certain key employees while they are serving in good faith in their capacities. Through December 31, 2023, there have been no claims under any indemnification provisions. Litigation From time to time, and in the ordinary course of business, the Company may be subject to various claims, charges, and litigation. On September 14, 2020, the Company received a letter from Teladoc Health, Inc. alleging that certain of the Company’s cart products and associated peripherals infringe upon their patents. On October 12, 2020, Teladoc Health, Inc filed a claim against the Company related to these allegations. On June 30, 2022, the claim was dismissed pursuant to a confidential settlement between the parties. As of December 31, 2023 and 2022, the Company did no t have any pending claims, charges or litigation that it expects would have a material adverse effect on its consolidated financial position, results of operations or cash flows.

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for commitments and contingencies. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 440 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 450 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//450/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 954 -SubTopic 440 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 440 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 440 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//440/tableOfContent + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration